All In MedTech

Device Trial Radar · NCT06557499

A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.

A Randomized, Data Analyst-masked, 3-way Cross-over, Pivotal Clinical Investigation to Evaluate the Performance of Two Polyurethane Male Condoms With Different Size and Thickness in Healthy Monogamous Couples During Vaginal Intercourse Compared With a Commercially Available Thin Latex Male Condom.

Last checked: Nov 19, 2026Latest source record: Jul 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 598 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

598

Actual

Start

Aug 23, 2024

Primary completion

Jul 11, 2025

Study completion Jul 11, 2025

Sponsor

Lead sponsor
Reckitt Benckiser Healthcare (UK) LimitedNot on our public-company list
Sponsor type
Industry
Collaborators
Novotech (Australia) Pty Limited
First posted
Aug 16, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This investigation is designed to evaluate the performance rate of two polyurethane male condoms with different sizes and thicknesses versus a standard natural rubber latex (NRL) male condom. The purpose of this study is to see how well the experimental condoms perform compared to the latex rubber condom (for example, how often the different condom types break or slip off the penis). Sponsor also wants to find out how well couples like using the three condom types and whether they experience any problems when using the condoms (for example, irritation or discomfort).

Conditions

  • Contraception

Interventions

  • Polyurethane (PU) male condom-Test condom 1- PU 57 mmDevice

    A minimum of 5 condoms of each condom type will be provided to couples to be used during vaginal intercourse over a maximum 5-week period (assessment period). Couples will repeat the assessment period for each of the 3 condom types.

  • Polyurethane (PU) male condom-Test condom 2- PU 63 mmDevice

    A minimum of 5 condoms of each condom type will be provided to couples to be used during vaginal intercourse over a maximum 5-week period (assessment period). Couples will repeat the assessment period for each of the 3 condom types.

  • Natural Rubber Latex (NRL) male condom- Control condomDevice

    A minimum of 5 condoms of each condom type will be provided to couples to be used during vaginal intercourse over a maximum 5-week period (assessment period). Couples will repeat the assessment period for each of the 3 condom types.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total Clinical Failure Rate of Polyurethane (PU) Male (Test Condom 1: PU 57 mm) Condom Compared to Control Condom: Natural Rubber Latex (NRL) 57 mm Male Condom.Time frame: within 8 hours following each coital act for each condom use
  2. Total Clinical Failure Rate of Polyurethane (PU) Male (Test Condom 2: PU 63 mm) Condom Compared to Control Condom: Natural Rubber Latex (NRL) 57 mm Male Condom.Time frame: within 8 hours following each coital act for each condom use

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Essential Access Health-Berkeley

    Berkeley, California

  • Essential Access Health -Los Angeles

    Los Angeles, California

  • Essential Acess Health- Seattle

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.